|
|
||||||||
CUTTING EDGE |



*
National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Immunogenetics, Rockville, MD 20852; and
Department of Biochemistry, Molecular Biology, and Cell Biology, Northwestern University, Evanston, IL 60208
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Although the discreet developmental stages of B cells are well defined (2, 3, 4), the molecular mechanisms that underlie the differential response to Ags in mature and immature cells remain to be elucidated (5). Recent studies of B cell Ag receptor (BCR)3 function in mature B cells have revealed a previously unappreciated step in BCR-induced activation following Ag encounter (reviewed in 6). Following cross-linking, the BCR was observed to rapidly translocate into specialized cholesterol- and sphingolipid-rich membrane microdomains, termed lipid rafts (7). The lipid rafts appear to serve as platforms for BCR signaling and concentrate the Src family kinase Lyn, as well as regulators of Lyn function (7, 8), and exclude the phosphatase CD45 (7). Following cross-linking, the BCR and Lyn in the lipid rafts were phosphorylated, and the BCR was subsequently rapidly targeted into the cell (7). Thus, lipid rafts appear to serve as a platform for both BCR signaling and trafficking in mature B cells.
Here we characterize the location of the BCR in the immature B cell line, WEHI-231, following cross-linking and provide evidence that the translocation of the BCR into lipid rafts defines an early step in the BCR signaling pathway that discriminates the response to Ags in immature and mature B cells.
| Materials and Methods |
|---|
|
|
|---|
The cell lines CH27 (9) and WEHI-231 and A20 (American Type Culture Collection, Manassas, VA) were maintained as described (10).
The phosphotyrosine-specific mAb containing HRP, RC20H, was purchased
from BD Transduction Laboratories (San Diego, CA).
F(ab')2 goat Abs specific for mouse IgG + IgM
(F(ab')2 anti-Ig) or mouse IgM
(F(ab')2 anti-IgM), fluorescein-conjugated
whole and F(ab')2 goat Abs specific for mouse IgM
(FL-anti-IgM and FL-F(ab')2 anti-IgM),
and nonspecific, isotype control F(ab')2 goat IgG
(F(ab')2 Ig) were purchased from Jackson
ImmunoResearch (West Grove, PA). Fab goat Abs specific for mouse IgM
(Fab anti-IgM) or mouse IgG (Fab anti-IgG) and HRP-conjugated
goat Abs specific for mouse IgG + IgM (HRP-anti-Ig) or rabbit IgG
(HRP-anti-rabbit) were also purchased from Jackson ImmunoResearch.
WS-2, affinity-purified rabbit polyclonal Abs specific for the
cytoplasmic domain of Ig
, were previously described
(11). HRP-conjugated cholera toxin B subunit (HRP-CTB) was
purchased from Sigma (St. Louis, MO). Fab anti-IgM and Fab
anti-IgG were iodinated as described (12).
Raft isolation and fluorometry
Membrane rafts from 1 x 107 cells were isolated on OptiPrep gradients as described (13). Aliquots of fractions from the OptiPrep gradient were diluted 1:4 in 10 mM Tris, pH 9.0, and analyzed on an ISS-PC1 spectrofluorometer ISS (Champagne, IL).
Apoptosis assay
Cells were incubated in 100 µl binding buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2) containing 5 ml FITC-annexin V (BD PharMingen, San Diego, CA) and propidium iodide (5 µg/ml) (BD PharMingen) at 25oC in the dark for 15 min. Binding buffer (400 µl) was added to dilute the samples before analysis on a flow cytometer. Cells positively labeled for both annexin V and propidium iodide were considered apoptotic.
| Results and Discussion |
|---|
|
|
|---|
40% of
the BCR was present in the lipid raft fraction of the gradient,
fraction 2. The remainder of the FL-F(ab')2
anti-IgM was found in the soluble membrane fraction 4 and in the
intermediate soluble fraction, fraction 3. The amount of the BCR in the
raft fractions decreased after 1020 min at 37°C such that by 60 min
<15% of the BCR was in the rafts.
|
3% of
the BCR localized to the raft region 1030 min after warming to
37°C. The vast majority of the FL-F(ab')2
anti-IgM remained in the soluble fraction, fraction 4. These
results indicate that the BCR on WEHI-231 cells does not significantly
translocate into Triton X-100 insoluble lipid rafts upon
cross-linking.
To investigate the position of the BCR in the earliest times after BCR
cross-linking the cells were incubated with
125I-labeled Fab anti-Ig for 15 min at 4°C
to label the BCR. The BCR was cross-linked using anti-Ig or an
isotype-matched control Ig, and the cells were incubated at 37°C for
1, 10, or 30 min. The rafts were isolated, and the amount of
125I-Fab anti-Ig was determined. No
translocation of the BCR into lipid rafts was detected in WEHI-231
cells, while a significant fraction of the BCR in CH27 cells was
detected in the raft fraction at 1 min following cross-linking, which
increased over the 30-min incubation at 37°C (Fig. 2
). Thus, translocation of the BCR is not
observed at any time following BCR cross-linking in WEHI-231 cells.
|
in the gradient fractions, detected by
immunoblotting, correlated with the presence of the
125I-Fab anti-IgM shown in Fig. 2
were found
exclusively in the soluble membrane fraction (Fig. 3
into the raft fractions. The maximum movement was detected 10
and 30 min after cross-linking. In contrast, the position of the BCR
µ-chain and Ig
in WEHI-231 cells in the soluble membrane fraction
was not altered by the addition of the cross-linking reagent. Both the
µ-chain and Ig
were detected only in the soluble fractions. Taken
together, these results indicate that the plasma membrane of WEHI-231
contains GM1-positive, Triton X-100 insoluble,
membrane microdomains, but these do not stably accommodate the BCR upon
cross-linking.
|
(7). The response to BCR
cross-linking in WEHI-231, CH27, and a second mature IgG-expressing
cell line, A20, was determined. To do so, cells were treated as
described in Fig. 2
In the absence of cross-linking, there was a constitutive low level of
phosphotyrosine-containing proteins in the raft membrane fractions of
the WEHI-231, CH27, and A20 cells (Fig. 4
). Immediately upon cross-linking, the
number and intensity of the phosphotyrosine containing proteins
increased dramatically in the raft fractions of the CH27 and A20 cells.
The phosphoprotein pattern was most intense immediately upon
cross-linking and decreased upon warming to 37°C for 1 and 10 min.
Significantly, the pattern of tyrosine-phosphorylated
proteins in the WEHI-231 raft fractions did not change upon BCR
cross-linking. However, the number and intensity of the
phosphorylated proteins increased dramatically in the
soluble fractions of WEHI-231 cells following treatment with the BCR
cross-linking reagent (Fig. 4
), indicating that the BCR cross-linking
triggered a response in the WEHI-231 cells. A similar pattern was
observed in the soluble fractions of both the A20 and CH27 cells. In
addition to the induction of protein phosphorylation,
treatment of WEHI-231 cells with
F(ab')2-anti-IgM induced apoptosis in
15% of the cells by 24 h (Table I
), which increased to
50% by 48
h (data not shown) but had no effect on CH27 cells, as previously
described (14, 15). Taken together, these results provide
evidence that cross-linking the BCR on WEHI-231 cells induces signaling
resulting in protein tyrosine phosphorylation and
apoptosis.
|
|
40% by 15 min for A20 cells
and 25% by 40 min for CH27 cells (Fig. 5
25% by 40 min, and the
rate and amount of internalization are unchanged by BCR cross-linking.
Thus, the BCR expressed on WEHI-231 cell surfaces does not undergo
accelerated internalization upon cross-linking, suggesting that
raft-dependent BCR internalization may not function in WEHI-231
cells.
|
Weintraub et al. (18) recently provided evidence that the BCR in tolerant B cells is not efficiently translocated into lipid rafts following cross-linking. The tolerant B cells were obtained from double-transgenic mice expressing a hen egg lysozyme (HEL)-specific BCR and soluble HEL. The HEL-specific B cells in these transgenic mice presumably encountered HEL at an immature stage, which resulted in induction of tolerance. The results presented here suggest the possibility that the exclusion from the lipid rafts is not a repercussion of tolerance induction but rather a reflection of the position of the BCR in the plasma membrane of immature B cells at the time of Ag contact. It will be of interest to determine whether the lipid rafts in B cells of other discrete developmental and differentiated stages function similarly.
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Susan K. Pierce, National Institute of Allergy and Infectious Diseases/National Institutes of Health/Twinbrook II, 12441 Parklawn Drive, Room 200B, MSC 8180, Rockville, MD 20852-8180. ![]()
3 Abbreviations used in this paper: BCR, B cell Ag receptor; CTB, cholera toxin B subunit; HEL, hen egg lysozyme. ![]()
Received for publication July 24, 2000. Accepted for publication September 26, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Blery, L. Tze, L. A. Miosge, J. E. Jun, and C. C. Goodnow Essential role of membrane cholesterol in accelerated BCR internalization and uncoupling from NF-{kappa}B in B cell clonal anergy J. Exp. Med., July 10, 2006; 203(7): 1773 - 1783. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Rotolo, J. Zhang, M. Donepudi, H. Lee, Z. Fuks, and R. Kolesnick Caspase-dependent and -independent Activation of Acid Sphingomyelinase Signaling J. Biol. Chem., July 15, 2005; 280(28): 26425 - 26434. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Karnell, R. J. Brezski, L. B. King, M. A. Silverman, and J. G. Monroe Membrane Cholesterol Content Accounts for Developmental Differences in Surface B Cell Receptor Compartmentalization and Signaling J. Biol. Chem., July 8, 2005; 280(27): 25621 - 25628. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hao and A. August Actin Depolymerization Transduces the Strength of B-Cell Receptor Stimulation Mol. Biol. Cell, May 1, 2005; 16(5): 2275 - 2284. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mielenz, C. Vettermann, M. Hampel, C. Lang, A. Avramidou, M. Karas, and H.-M. Jack Lipid Rafts Associate with Intracellular B Cell Receptors and Exhibit a B Cell Stage-Specific Protein Composition J. Immunol., March 15, 2005; 174(6): 3508 - 3517. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Herrin, A. L. Groeger, and L. B. Justement The Adaptor Protein HSH2 Attenuates Apoptosis in Response to Ligation of the B Cell Antigen Receptor Complex on the B Lymphoma Cell Line, WEHI-231 J. Biol. Chem., February 4, 2005; 280(5): 3507 - 3515. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Edry and D. Melamed Receptor Editing in Positive and Negative Selection of B Lymphopoiesis J. Immunol., October 1, 2004; 173(7): 4265 - 4271. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Hao, G. B. Carey, and X. Zhan Syk-mediated Tyrosine Phosphorylation Is Required for the Association of Hematopoietic Lineage Cell-specific Protein 1 with Lipid Rafts and B Cell Antigen Receptor Signalosome Complex J. Biol. Chem., August 6, 2004; 279(32): 33413 - 33420. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Setterblad, S. Becart, D. Charron, and N. Mooney B Cell Lipid Rafts Regulate Both Peptide-Dependent and Peptide-Independent APC-T Cell Interaction J. Immunol., August 1, 2004; 173(3): 1876 - 1886. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ehrhardt, M. D. David, G. R. A. Ehrhardt, and J. W. Schrader Distinct Mechanisms Determine the Patterns of Differential Activation of H-Ras, N-Ras, K-Ras 4B, and M-Ras by Receptors for Growth Factors or Antigen Mol. Cell. Biol., July 15, 2004; 24(14): 6311 - 6323. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Shrivastava, T. Katagiri, M. Ogimoto, K. Mizuno, and H. Yakura Dynamic regulation of Src-family kinases by CD45 in B cells Blood, February 15, 2004; 103(4): 1425 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. C. Chan, D. Hughes, R. R. French, A. L. Tutt, C. A. Walshe, J. L. Teeling, M. J. Glennie, and M. S. Cragg CD20-induced Lymphoma Cell Death Is Independent of Both Caspases and Its Redistribution into Triton X-100 Insoluble Membrane Rafts Cancer Res., September 1, 2003; 63(17): 5480 - 5489. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-K. Yi, J.-G. Yoon, and A. M. Krieg Convergence of CpG DNA- and BCR-mediated signals at the c-Jun N-terminal kinase and NF-{kappa}B activation pathways: regulation by mitogen-activated protein kinases Int. Immunol., May 1, 2003; 15(5): 577 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gupta and A. L. DeFranco Visualizing Lipid Raft Dynamics and Early Signaling Events during Antigen Receptor-mediated B-Lymphocyte Activation Mol. Biol. Cell, February 1, 2003; 14(2): 432 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Petrie and J. P. Deans Colocalization of the B Cell Receptor and CD20 Followed by Activation-Dependent Dissociation in Distinct Lipid Rafts J. Immunol., September 15, 2002; 169(6): 2886 - 2891. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dykstra, A. Cherukuri, and S. K. Pierce Rafts and synapses in the spatial organization of immune cell signaling receptors J. Leukoc. Biol., November 1, 2001; 70(5): 699 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Benschop, E. Brandl, A. C. Chan, and J. C. Cambier Unique Signaling Properties of B Cell Antigen Receptor in Mature and Immature B Cells: Implications for Tolerance and Activation J. Immunol., October 15, 2001; 167(8): 4172 - 4179. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. HASLER and M. ZOUALI B cell receptor signaling and autoimmunity FASEB J, October 1, 2001; 15(12): 2085 - 2098. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Drake III and T. J. Braciale Cutting Edge: Lipid Raft Integrity Affects the Efficiency of MHC Class I Tetramer Binding and Cell Surface TCR Arrangement on CD8+ T Cells J. Immunol., June 15, 2001; 166(12): 7009 - 7013. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Cheng, B. K. Brown, W. Song, and S. K. Pierce Translocation of the B Cell Antigen Receptor into Lipid Rafts Reveals a Novel Step in Signaling J. Immunol., March 15, 2001; 166(6): 3693 - 3701. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |